ConductScience.org, home

Paper24103641

Time-dependence of risperidone and asenapine sensitization and associated D2 receptor mechanism.

Gao J and 1 other. Behav Brain Res, 2013. Cited by 19 papers, by iCite.

Cite this record

ConductScience Library. Time-dependence of risperidone and asenapine sensitization and associated D2 receptor mechanism. Papers, record 24103641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24103641

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Time-dependence of risperidone and asenapine sensitization and associated D2 receptor mechanism.
PubMed
Journal
Behav Brain Res
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
0.83
iCite
Revised in PubMed
2021-12-03
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gao JJun
2Li MMing

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antipsychotic AgentsMajor topic
Avoidance LearningMajor topic
Heterocyclic Compounds, 4 or More RingsMajor topic
Receptors, Dopamine D2Major topic
RisperidoneMajor topic
Analysis of Variance
Animals
Dibenzocycloheptenes
Dopamine Agonists
Dose-Response Relationship, Drug
Drug Administration Schedule
Hyperkinesis
Male
Quinpirole
Rats
Rats, Sprague-Dawley
Time Factors

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 MH085635NIMH NIH HHSUnited StatesR01MH085635PubMed and NIH
R01MH085635NIMH NIH HHSUnited StatesR01MH085635PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References66

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123954676Repeated asenapine treatment produces a sensitization effect in two preclinical tests of antipsychotic activity.Neuropharmacology2013https://conductscience.org/library/papers/23954676PubMed
216490410How antipsychotics work-from receptors to reality.NeuroRx2006https://conductscience.org/library/papers/16490410PubMed
32506596Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpiride.Psychopharmacology (Berl)1989https://conductscience.org/library/papers/2506596PubMed
419875272Effects of repeated risperidone exposure on serotonin receptor subtypes in developing rats.Eur Neuropsychopharmacol2010https://conductscience.org/library/papers/19875272PubMed
522362425Involvement of 5-HT2A receptor and α2-adrenoceptor blockade in the asenapine-induced elevation of prefrontal cortical monoamine outflow.Synapse2012https://conductscience.org/library/papers/22362425PubMed
623026062Avoidance disruptive effect of clozapine and olanzapine is potentiated by increasing the test trials: further test of the motivational salience hypothesis.Pharmacol Biochem Behav2013https://conductscience.org/library/papers/23026062PubMed
711396519NMDA receptor antagonists do not block the development of sensitization of catalepsy, but make its expression state-dependent.Behav Pharmacol2001https://conductscience.org/library/papers/11396519PubMed
823121334The preclinical profile of asenapine: clinical relevance for the treatment of schizophrenia and bipolar mania.Expert Opin Drug Discov2013https://conductscience.org/library/papers/23121334PubMed
918308814Asenapine: a novel psychopharmacologic agent with a unique human receptor signature.J Psychopharmacol2009https://conductscience.org/library/papers/18308814PubMed
1011303062Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: implications for antipsychotic drug treatment.J Pharmacol Exp Ther2001https://conductscience.org/library/papers/11303062PubMed
1117940749Asenapine, a novel psychopharmacologic agent: preclinical evidence for clinical effects in schizophrenia.Psychopharmacology (Berl)2008https://conductscience.org/library/papers/17940749PubMed
1221402097Time course of the attenuation effect of repeated antipsychotic treatment on prepulse inhibition disruption induced by repeated phencyclidine treatment.Pharmacol Biochem Behav2011https://conductscience.org/library/papers/21402097PubMed
1310889544Time-dependent sensitization: the odyssey of a scientific heresy from the laboratory to the door of the clinic.Mol Psychiatry2000https://conductscience.org/library/papers/10889544PubMed
143768722Behavioral effects of a single neuroleptic treatment grow with the passage of time.Brain Res1986https://conductscience.org/library/papers/3768722PubMed
1519179852Olanzapine and risperidone disrupt conditioned avoidance responding in phencyclidine-pretreated or amphetamine-pretreated rats by selectively weakening motivational salience of conditioned stimulus.Behav Pharmacol2009https://conductscience.org/library/papers/19179852PubMed
1611057521Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study.Psychopharmacology (Berl)2000https://conductscience.org/library/papers/11057521PubMed
1723092709Environmental and behavioral controls of the expression of clozapine tolerance: evidence from a novel across-model transfer paradigm.Behav Brain Res2013https://conductscience.org/library/papers/23092709PubMed
1822025698Discovery of β-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy.Proc Natl Acad Sci U S A2011https://conductscience.org/library/papers/22025698PubMed
193309709Quinpirole hydrochloride, a potential anti-parkinsonism drug.Neuropharmacology1987https://conductscience.org/library/papers/3309709PubMed
2022647577Hyperactivity induced by the dopamine D2/D3 receptor agonist quinpirole is attenuated by inhibitors of endocannabinoid degradation in mice.Int J Neuropsychopharmacol2013https://conductscience.org/library/papers/22647577PubMed

See all 66 referencesDownload CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
42168165"Intranasal clozapine sol-gel formulation induces an antipsychotic effect at a fraction of a comparable oral therapeutic dose".Transl Psychiatry2026https://conductscience.org/library/papers/42168165PubMed
38582275Continuous oral olanzapine or clozapine treatment initiated in adolescence has differential short- and long-term impacts on antipsychotic sensitivity than those initiated in adulthood.Eur J Pharmacol2024https://conductscience.org/library/papers/38582275PubMed
37615683
Effort-related effects of chronic administration of the DA D2 receptor antagonist haloperidol via subcutaneous programmable minipumps: Reversal by co-administration of the adenosine A2A antagonist istradefylline.
Psychopharmacology (Berl)2023https://conductscience.org/library/papers/37615683PubMed
33515643Maternal immune activation and repeated maternal separation alter offspring conditioned avoidance response learning and antipsychotic response in male rats.Behav Brain Res2021https://conductscience.org/library/papers/33515643PubMed
32756473The Effects of Antipsychotics on the Synaptic Plasticity Gene Homer1a Depend on a Combination of Their Receptor Profile, Dose, Duration of Treatment, and Brain Regions Targeted.Int J Mol Sci2020https://conductscience.org/library/papers/32756473PubMed
27371498Antipsychotic-induced sensitization and tolerance: Behavioral characteristics, developmental impacts, and neurobiological mechanisms.J Psychopharmacol2016https://conductscience.org/library/papers/27371498PubMed
26586334Effects of repeated quetiapine treatment on conditioned avoidance responding in rats.Eur J Pharmacol2015https://conductscience.org/library/papers/26586334PubMed
26049127Adolescent olanzapine sensitization is correlated with hippocampal stem cell proliferation in a maternal immune activation rat model of schizophrenia.Brain Res2015https://conductscience.org/library/papers/26049127PubMed
25586399
Repeated administration of aripiprazole produces a sensitization effect in the suppression of avoidance responding and phencyclidine-induced hyperlocomotion and increases D2 receptor-mediated behavioral function.
J Psychopharmacol2015https://conductscience.org/library/papers/25586399PubMed
25093543Asenapine sensitization from adolescence to adulthood and its potential molecular basis.Behav Brain Res2014https://conductscience.org/library/papers/25093543PubMed
24942467Differential effects of intermittent versus continuous haloperidol treatment throughout adolescence on haloperidol sensitization and social behavior in adulthood.Prog Neuropsychopharmacol Biol Psychiatry2014https://conductscience.org/library/papers/24942467PubMed
24363078Long-lasting sensitization induced by repeated risperidone treatment in adolescent Sprague-Dawley rats: a possible D2 receptor mediated phenomenon?Psychopharmacology (Berl)2014https://conductscience.org/library/papers/24363078PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
DRD21813PubTator's text mininghttps://conductscience.org/library/genes/1813

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24103641

GET https://conductscience.org/api/papers/v1/24103641/references?page=2